Posted On: 11/10/2014 9:47:14 AM
Post# of 30066
Churbz: We really need the test results from the expanded LP002 test and the 12 week validation test being done by ICON before we can start signing up pharmas doing AD clinical trials.
Gerald told me face to face more than once that their objective initially after launching Lympro was to gain the confidence of KOLs and BP in the Alzheimer's industry.....even more important initially than generating revenue. I think they want to move slowly and tweak LymPro as they go to make sure it is absolutely reliable. Once LymPro has been used successfully by several BP doing trials, then the AD industry will be ready to anoint LymPro as the "Industry Standard" AD diagnostic blood test. Once that happens...revenue will explode.
I will be happy just hearing Lympro is being used by pharmas doing clinical trials. That is huge. Everything else will follow naturally. I understand why Gerald wants to bring Lympro along carefully. If they stub their toe, that would blow their reputation forever.
Gerald told me face to face more than once that their objective initially after launching Lympro was to gain the confidence of KOLs and BP in the Alzheimer's industry.....even more important initially than generating revenue. I think they want to move slowly and tweak LymPro as they go to make sure it is absolutely reliable. Once LymPro has been used successfully by several BP doing trials, then the AD industry will be ready to anoint LymPro as the "Industry Standard" AD diagnostic blood test. Once that happens...revenue will explode.
I will be happy just hearing Lympro is being used by pharmas doing clinical trials. That is huge. Everything else will follow naturally. I understand why Gerald wants to bring Lympro along carefully. If they stub their toe, that would blow their reputation forever.
(0)
(0)
